» Articles » PMID: 23824394

Risk Factors for Metastatic Disease at Presentation with Osteosarcoma: an Analysis of the SEER Database

Overview
Date 2013 Jul 5
PMID 23824394
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteosarcoma is the most common primary bone sarcoma and affects all ages. There are substantial differences in management and outcomes for patients who have localized disease compared with distant spread at the time of diagnosis. Our goal was to examine potential risk factors predictive of metastatic disease at presentation.

Methods: The Surveillance, Epidemiology, and End Results (SEER) Program database was used to identify all patients diagnosed with osteosarcoma from 2000 to 2008 and to classify each patient as having metastatic or localized disease at the time of diagnosis. Patient-based characteristics, tumor characteristics, and county-level socioeconomic measures were analyzed to determine which factors were predictive of an increased rate of distant metastatic disease at presentation. These factors were analyzed as univariate characteristics as well as in a multivariate logistic regression model.

Results: We identified 2017 cases of high-grade osteosarcoma, and 464 (23.0%) of the patients presented with metastatic disease. In the unadjusted logistic regression analysis, patients had increased odds of metastatic disease at presentation if they had an age of sixty years or more (odds ratio [OR] = 2.22; 95% confidence interval [CI], 1.71 to 2.89), had a tumor located in the axial skeleton (OR = 2.47; 95% CI, 1.88 to 3.26), and lived in a county with low socioeconomic status (OR = 1.59; 95% CI, 1.08 to 2.35). These factors remained significant when combined in multivariate models controlling for age, location, and socioeconomic status. For patients with recorded tumor size information (n = 1398), the odds of metastasis at presentation increased by 10% with each additional centimeter of tumor size (OR = 1.10; 95% CI, 1.08 to 1.13). When the patients with missing tumor size information were excluded, socioeconomic status was no longer a significant risk factor for metastasis at presentation in the multivariate model.

Conclusions: Osteosarcoma patients with advanced age, a tumor in the axial skeleton, a larger tumor size, and a residence in a less affluent county were more likely to have metastatic disease at presentation.

Citing Articles

Identification of telomere-related gene subtypes and prognostic signatures in osteosarcoma.

Song Z, Yu W, Yin X Front Pharmacol. 2025; 16:1545913.

PMID: 40070565 PMC: 11893505. DOI: 10.3389/fphar.2025.1545913.


The Role of mRNA Modifications in Bone Diseases.

Li Z, Meng K, Lan S, Ren Z, Lai Z, Ao X Int J Biol Sci. 2025; 21(3):1065-1080.

PMID: 39897026 PMC: 11781163. DOI: 10.7150/ijbs.104460.


Global, regional, and national burden of malignant neoplasm of bone and articular cartilage in adults aged 65 years and older, 1990-2021: a systematic analysis based on the global burden of disease study 2021.

Zhang X, Dai X, Chen Y, Wang S, Yang H, Qu B Aging Clin Exp Res. 2025; 37(1):21.

PMID: 39776003 PMC: 11711276. DOI: 10.1007/s40520-024-02926-0.


Odds of Metastatic Disease at Diagnosis of Primary Bone and Soft-Tissue Sarcomas of the Extremity and Pelvis Based on Preferred Language and Socioeconomic Factors.

Garcia A, Tyler W J Am Acad Orthop Surg. 2024; 33(6):319-326.

PMID: 39729593 PMC: 11855999. DOI: 10.5435/JAAOS-D-24-00634.


Comprehensive analysis of splicing factor SRs-related gene characteristics: predicting osteosarcoma prognosis and immune regulation status.

Long C, Ma B, Li K, Liu S Front Oncol. 2024; 14:1456986.

PMID: 39286028 PMC: 11403285. DOI: 10.3389/fonc.2024.1456986.


References
1.
Spanier S, Shuster J, Vander Griend R . The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am. 1990; 72(5):643-53. View

2.
Marlow N, Halpern M, Pavluck A, Ward E, Chen A . Disparities associated with advanced prostate cancer stage at diagnosis. J Health Care Poor Underserved. 2010; 21(1):112-31. DOI: 10.1353/hpu.0.0253. View

3.
Crawford S, Sauerzapf V, Haynes R, Forman D, Jones A . Social and geographical factors affecting access to treatment of colorectal cancer: a cancer registry study. BMJ Open. 2012; 2(2):e000410. PMC: 3341592. DOI: 10.1136/bmjopen-2011-000410. View

4.
Ferrari S, Bertoni F, Mercuri M, Picci P, Giacomini S, Longhi A . Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol. 2001; 12(8):1145-50. DOI: 10.1023/a:1011636912674. View

5.
Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z . Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer. 2011; 117(18):4277-85. DOI: 10.1002/cncr.25969. View